Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Therapeutics    entities : Vivos therapeutics inc    save search

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVST | $19.75 0.82% -3.78% 2M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

year update therapeutics financial results
Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds
Published: 2024-02-15 (Crawled : 13:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: -0.79% H: 10.01% C: 6.99%

million therapeutics
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
Published: 2024-02-06 (Crawled : 12:30) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 11.65% H: 0.47% C: -14.8%

favorable therapeutics growth market
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA
Published: 2024-01-08 (Crawled : 12:30) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 4.93% H: 1.82% C: -3.47%

fda positive treat clearance medical therapeutics
Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
Published: 2023-12-11 (Crawled : 12:30) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 0.52% H: 3.31% C: -14.88%

women therapeutics
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
Published: 2023-11-29 (Crawled : 12:30) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 171.75% H: 308.97% C: 243.67%

fda device treatment clearance therapeutics
Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update
Published: 2023-11-14 (Crawled : 21:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 5.9% H: 8.86% C: -2.53%
NVST | $19.75 0.82% -3.78% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.76% H: 5.28% C: 4.78%

update therapeutics financial results
Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -5.84%

conference therapeutics financial results
Vivos Therapeutics Closes $4 Million Private Placement
Published: 2023-11-02 (Crawled : 21:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: -3.87% H: 10.06% C: -1.72%

therapeutics
Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Published: 2023-10-31 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: -6.27% H: 0.0% C: -10.58%

nasdaq therapeutics
Vivos Therapeutics Announces Reverse Stock Split1-for-25 reverse stock split to become effective as of the opening of trading tomorrow, October 27, 2023
Published: 2023-10-26 (Crawled : 14:00) - biospace.com/
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 1.29% H: 1.77% C: -8.09%

therapeutics
Vivos Therapeutics Announces Reverse Stock Split
Published: 2023-10-26 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 1.29% H: 1.77% C: -8.09%

therapeutics
Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare
Published: 2023-10-24 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 11.51% H: 0.97% C: -15.48%

distribution therapeutics agreement
Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: -5.09% H: 16.09% C: 9.37%

trial therapeutics
Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion
Published: 2023-10-05 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 15.63% H: 1.96% C: -7.55%

international expansion collaboration therapeutics africa
Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers
Published: 2023-10-04 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 45.95% H: 66.59% C: 12.78%
NVST | $19.75 0.82% -3.78% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 0.52% C: -0.66%

network therapeutics
Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update
Published: 2023-08-16 (Crawled : 20:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: -1.64% H: 3.68% C: -1.27%

update therapeutics financial results
Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call
Published: 2023-08-16 (Crawled : 12:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 5.53% H: 0.0% C: 0.0%

conference therapeutics results
Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call
Published: 2023-08-14 (Crawled : 21:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: -9.3% H: 0.0% C: 0.0%

conference therapeutics financial results
Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call
Published: 2023-08-11 (Crawled : 00:00) - globenewswire.com
VVOS | $2.66 -2.66% 63K twitter stocktwits trandingview |
Health Technology
| | O: 6.46% H: 13.91% C: 12.81%

conference therapeutics financial results
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.